TUMS DUAL ACTION

Erosive, but Not Nonerosive, GERD Ups Esophageal CA Risk

April 26, 2012

Patients with gastroesophageal reflux disease with a history of esophagitis are at increased risk for esophageal adenocarcinoma, although the absolute risk is low.

Low Gastroprotective Drug Adherence Ups Upper GI Events

April 17, 2012

For patients taking cyclooxygenase-2 inhibitors (coxibs), low adherence to gastroprotective agents (GPAs) increases the risk of upper gastrointestinal (UGI) complications.

More Gastro Events in Patients With Rheumatoid Arthritis

April 11, 2012

The incidence of upper and lower gastrointestinal (GI) events is higher among patients with rheumatoid arthritis (RA), as is the risk of mortality due to GI events, when compared to individuals without RA.

Smoking Found to Be a Risk Factor for Barrett's Esophagus

April 11, 2012

Cigarette smoking may be a modifiable risk factor for Barrett's esophagus.

New Device Approved for Lingering GERD

March 26, 2012

The LINX Reflux Management System has been approved by the U.S. Food and Drug Administration to treat people with gastroesophageal reflux disease (GERD) who continue to have chronic symptoms, despite taking maximum medication and making recommended lifestyle changes.

BENTYL

Gastrointestinal Tract > Hyperacidity, GERD, and ulcers

Dicyclomine HCl 10mg caps; 20mg tabs.

CHILDREN'S GAS-X TONGUE TWISTERS THIN STRIPS

Gastrointestinal Tract > Hyperacidity, GERD, and ulcers

Simethicone 40mg; per thin strip; sweet cinnamon flavor.

DONNATAL EXTENTABS

Gastrointestinal Tract > Hyperacidity, GERD, and ulcers

Phenobarbital 48.6mg, hyoscyamine sulfate 0.3111mg, atropine sulfate 0.0582mg, scopolamine HBr 0.0195mg; ext-rel tabs.

NEXIUM for ORAL SUSPENSION

Gastrointestinal Tract > Hyperacidity, GERD, and ulcers

Esomeprazole (as magnesium trihydrate) 10mg, 20mg, 40mg; per packet; e-c delayed release granules.

Updated: 1/14/2010

ROBINUL

Gastrointestinal Tract > Hyperacidity, GERD, and ulcers

Glycopyrrolate 1mg; dye-free tabs.

Gastrointestinal Tract > Hyperacidity, GERD, and ulcers

The management of GERD focuses on the reduction of gastric acidity, increasing lower esophageal sphincter pressure, or enhancing esophageal motility. ...
more »

Treatment Update: PediPirox^™-4 Nail Kit (ciclopirox topical solution, 8%)

April 25, 2012

Update on Melanoma Treatment: SYLATRON™ (peg-interferon alfa-2b) for injection, for subcutaneous use

January 23, 2012

Acute Pain Update: SPRIX^® (ketorolac tromethamine) Nasal Spray 15.75 mg per spray

November 29, 2011

Irritable Bowel Syndrome (IBS) Treatments

February 09, 2012

Irritable Bowel Syndrome (IBS) dosing regimens chart (5-HT3 receptor antagonist, anticholinergic [with or without barbiturates or benzodiazepeines] GI motility enhancer).

Evaluation of Irritable Bowel Syndrome (IBS)

April 09, 2010

Irritable Bowel Syndrome (IBS) evaluation chart based on Manning Criteria and Rome III Diagnostic Criteria.

H. pylori Eradication Options for Peptic Ulcer Disease

October 08, 2009

Helicobacter pylori treatment chart for peptic ulcer disease.

Medications with Significant Anticholinergic Properties

October 01, 2009

Commonly prescribed medications that cause significant anticholinergic effect, plus a list of potential adverse consequences.

Gastroesophageal Reflux Disease Management Chart

January 08, 2009

Gastroesophageal reflex disease (GERD) management algorithm chart.